SEI Investments: Analysts Push Buy as Insiders Sell $13M in Coordinated Exit
Analysts are recommending a "Buy" for SEI Investments (SEIC), citing an undervalued stock, while company insiders have sold $13.1 million worth of stock, including a significant sale by the Chairman. This divergence, coupled with a 38.33% drop in institutional holders and SEI increasing its stake in a competitor, suggests a potential "pump-and-dump" scenario, raising red flags about the bullish narrative. The article advises monitoring 13F filings, future insider trading, and the next earnings report for clearer signals on SEIC's trajectory.
Key facts: UNH Slides on 0.09% Medicare Hike; RJ $330 Target; $447.6B
UnitedHealth (UNH) experienced a slight decline in stock value following a proposed 0.09% Medicare rate hike, which could impact Medicare Advantage margins. Despite this, Raymond James upgraded UNH to Outperform with a $330 target, anticipating G&A savings and improved visibility into Optum Health margins. The company, operating through health insurance and Optum units, reported $447.6 billion in trailing-12-month revenue, leveraging its scale for negotiations.
Trilogy Metals upgraded at Raymond James on Alaska copper project (TMQ:NYSE)
Trilogy Metals (TMQ) was upgraded to Outperform from Market Perform by Raymond James, with a C$8 price target. The upgrade is attributed to the company's copper exposure through the Arctic project in Alaska, which has the support of the Alaskan government and NANA. Trilogy Metals' stock was up 2.4% in Monday's trading following the news.
NewJersey Resources (NYSE:NJR) Reaches New 12-Month High - Here's What Happened
NewJersey Resources (NYSE:NJR) recently hit a new 52-week high of $56.04 per share during midday trading, driven by strong Q4 results that surpassed analyst expectations for both EPS and revenue. The company also provided optimistic FY2026 guidance. Analyst sentiment remains largely positive with a "Buy" consensus rating and the stock offers a 3.4% dividend yield, despite recent insider sales by some executives.
RJF: Jefferies Lowers Price Target for Raymond James Financial
Jefferies has lowered its price target for Raymond James Financial (RJF) from $165.00 to $145.00, while maintaining a 'Hold' rating. This adjustment reflects a cautious market sentiment despite the firm's diversified financial services, which are largely driven by its wealth management franchise in the United States. Wall Street analysts currently forecast an average price target of $183.10 for RJF, implying a potential upside of 28.56% from its current price.
Jefferies Financial Group Lowers Charles Schwab (NYSE:SCHW) Price Target to $118.00
Jefferies Financial Group has lowered its price target for Charles Schwab (NYSE:SCHW) to $118.00 from $122.00, while maintaining a "buy" rating. The financial services provider recently reported strong quarterly earnings, beating analyst expectations with $1.39 EPS and $6.34 billion in revenue, and set a positive FY2026 guidance. Despite insider selling, the consensus among analysts is a "Moderate Buy" rating with an average target price of $115.95.
Raymond James Adjusts Price Target on Intercontinental Exchange to $222 From $215, Maintains Strong Buy Rating
Raymond James has increased its price target for Intercontinental Exchange (NYSE:ICE) to $222 from $215, while reaffirming a strong buy rating for the company's stock. This adjustment reflects the analyst's continued confidence in ICE's financial performance and future prospects.
Jefferies Maintains Raymond James Financial(RJF.US) With Hold Rating, Raises Target Price to $145
Jefferies has reiterated its Hold rating on Raymond James Financial (RJF.US) while simultaneously increasing its target price for the stock to $145. This adjustment reflects Jefferies' continued assessment of the company's value, suggesting a moderate outlook for its stock performance.
Raymond James upgrades Trilogy Metals stock rating on Alaska project By Investing.com
Raymond James upgraded Trilogy Metals (NYSE:TMQ) to Outperform from Market Perform, setting a price target of Cdn$8.00, citing the company's base metals development opportunity through its Arctic project in Alaska. The stock has seen a 165% return over the past year, though InvestingPro analysis suggests it is overvalued despite a "GOOD" financial health score. The upgrade comesamid other recent developments for Trilogy Metals, including new analyst coverage, executive appointments, a significant stake divestment by John Paulson, and expansion of its advisory team.
Wolfe Research Issues Positive Forecast for Devon Energy (NYSE:DVN) Stock Price
Wolfe Research raised its target price for Devon Energy (NYSE:DVN) to $65 from $64, maintaining an "outperform" rating and implying a 30.84% upside. This positive forecast comes after Devon Energy beat quarterly earnings expectations with an EPS of $0.82 and revenue of $4.12 billion. The company has a consensus "Moderate Buy" rating from analysts with an average price target of $51.39.
Raymond James Financial Issues Positive Forecast for CME Group (NASDAQ:CME) Stock Price
Raymond James Financial has increased its price target for CME Group (NASDAQ:CME) stock from $310 to $320, maintaining an "outperform" rating, indicating a potential 4.37% upside. This positive forecast follows CME's recent earnings beat with an EPS of $2.77 against estimates of $2.75, coupled with 8.1% revenue growth. While analysts generally assign a "Moderate Buy" rating with a consensus target of $304.65, insider transactions show recent sales of 8,539 shares, though institutional ownership remains high at 87.75%.
Raymond James cuts Phreesia stock price target on pharma ad headwinds
Raymond James has lowered its price target for Phreesia Inc. (NYSE:PHR) to $16 from $25, while maintaining an Outperform rating, due to headwinds in pharmaceutical advertising. Phreesia also reduced its fiscal 2027 revenue guidance by about 7% due to lower visibility in pharma ad spending, despite reporting better-than-expected Q4 fiscal 2026 results and maintaining its adjusted EBITDA guidance through cost controls. Other analysts like BMO Capital and DA Davidson also adjusted their price targets downwards, though KeyBanc maintained an Overweight rating.
Raymond James cuts Phreesia stock price target on pharma ad headwinds
Raymond James has lowered its price target for Phreesia Inc. (NYSE:PHR) to $16 from $25, citing headwinds in pharmaceutical advertising despite the company beating Q4 fiscal 2026 revenue and adjusted EBITDA estimates. Phreesia also reduced its fiscal 2027 revenue guidance by about 7% due to lower visibility in pharma ad spending, although it maintained its adjusted EBITDA guidance by planning cost controls through AI. Other analysts, including Citizens and BMO Capital, have also adjusted their ratings and price targets following Phreesia's updated outlook.
Goldman Sachs Adjusts PT on Raymond James Financial to $188 From $190, Maintains Buy Rating
Goldman Sachs has updated its price target for Raymond James Financial, decreasing it slightly to $188 from $190, while reiterating a "Buy" rating on the stock. This adjustment reflects a minor change in outlook for the financial services company. Other financial institutions like BMO Capital and Jefferies also recently adjusted their price targets and ratings for Raymond James Financial.
Intercontinental Exchange Inc - reports monthly volume of 428.9m contracts in March 2026
Intercontinental Exchange Inc. reported a monthly volume of 428.9 million contracts for March 2026. This announcement comes amidst other news for the company, including an 88% rise in March's average daily volume, and analyst price target adjustments from Raymond James and Goldman Sachs. The article is reserved for members, requiring registration or login to view the full content.
Seed Wealth Management Inc. Has $4.97 Million Stake in PGIM Ultra Short Bond ETF $PULS
Seed Wealth Management Inc. significantly increased its stake in PGIM Ultra Short Bond ETF (PULS) by 297.1% during the fourth quarter, now holding 100,114 shares valued at $4.97 million. This investment accounts for 3.4% of the firm's portfolio. Other institutional investors like JPMorgan Chase & Co., Bank of America Corp DE, and Raymond James Financial Inc. also hold substantial positions in PULS, which trades on NYSEARCA and recently declared a monthly dividend.
Raymond James raises Matador stock price target on updated estimates
Raymond James has increased its price target for Matador Resources Co. (NYSE:MTDR) to $76.00 from $59.00, maintaining an Outperform rating, citing updated estimates following commodity price movements and the company's recent financial activities. Matador recently completed a $750 million private placement, using the proceeds to redeem outstanding senior notes and reduce credit facility borrowings, and anticipates a 3% year-over-year increase in total production for 2026, alongside an 11% decrease in capital expenditures. Other analysts have also adjusted their targets, with BMO Capital raising its price target and KeyBanc Capital Markets identifying Matador as an oil-weighted stock likely to benefit from rising crude prices.
Jefferies Adjusts Price Target on Raymond James Financial to $145 From $165, Maintains Hold Rating
Jefferies has adjusted its price target for Raymond James Financial (NYSE:RJF) to $145, down from the previous $165, while maintaining a Hold rating on the stock. This revision reflects an updated valuation perspective from the firm.
Rathbones Group PLC Has $70.78 Million Holdings in The Walt Disney Company $DIS
Rathbones Group PLC significantly reduced its stake in The Walt Disney Company by 15.5%, but still holds 622,107 shares valued at $70.78 million. Despite this reduction, other large institutional investors like Viking Global Investors and Assenagon Asset Management increased their holdings. Disney reported strong Q4 earnings, beating estimates, and analysts maintain a "Moderate Buy" rating with a consensus price target of $132.81, though recent sentiment has been mixed with some upgrades and downgrades.
Jefferies Adjusts Price Target on Raymond James Financial to $145 From $165, Maintains Hold Rating
Jefferies has revised its price target for Raymond James Financial (RJF) shares to $145, down from the previous $165. Despite this reduction, the firm has decided to maintain its "Hold" rating on the financial services company. This adjustment reflects an updated valuation outlook for Raymond James Financial.
LPL Financial stock reiterated at outperform by Citizens on valuation
Citizens reiterated a Market Outperform rating and $500.00 price target on LPL Financial Holdings (NASDAQ:LPLA) stock, despite the stock's 18% year-to-date decline. The firm believes the underperformance is due to softer net new assets data, AI headline risk, and a broader market pullback, but sees the current dynamics as a compelling opportunity because the stock appears undervalued. LPL Financial recently reported increased advisory and brokerage assets and announced a partnership with Simplicity Group to enhance insurance offerings.
Genuine Parts Company Receives 'Moderate Buy' Rating from Analysts
Genuine Parts Company (NYSE:GPC) has received an average "Moderate Buy" rating from ten analysts, with an average 12-month price target of $145.57. The ratings include a mix of buy, strong buy, hold, and sell recommendations, reflecting diverse views on the company's future performance. Analysts' assessments incorporate recent financial news, including the company's latest earnings report and dividend announcement, offering insights into its competitive position within the automotive aftermarket industry.
GE Vernova Inc. $GEV Shares Bought by Sovran Advisors LLC
Sovran Advisors LLC significantly increased its stake in GE Vernova Inc. (GEV) by 120.8% in Q4, bringing its holdings to 2,199 shares valued at $1.41 million. This move is part of a broader trend of rising institutional interest in GEV, fueled by a major earnings beat, revenue exceeding expectations, and increased price targets from analysts due to demand for power in AI and data centers, as well as a new nuclear fuel deal. Despite strong fundamentals and a recently announced quarterly dividend, the stock faces short-term volatility risks and trades at a high valuation.
Savvy Advisors Inc. Takes $2.77 Million Position in Goldman Sachs Equal Weight U.S. Large Cap Equity ETF $GSEW
Savvy Advisors Inc. has acquired a new stake of 32,569 shares, valued at approximately $2.77 million, in the Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) during the fourth quarter. This makes the firm own 0.21% of GSEW. Several other institutional investors also modified their holdings in GSEW, indicating growing interest in the ETF.
SG Americas Securities LLC Purchases 13,884 Shares of Tompkins Financial Corporation $TMP
SG Americas Securities LLC significantly increased its stake in Tompkins Financial Corporation (NYSEAMERICAN:TMP) by 104.5% in the fourth quarter, acquiring an additional 13,884 shares to hold a total of 27,168 shares valued at approximately $1.97 million. Tompkins Financial reported strong fourth-quarter earnings, beating EPS expectations with $1.78 per share and revenue of $257.3 million, and also increased its quarterly dividend to $0.67, resulting in an annualized yield of 3.3%. Institutional investors and hedge funds collectively own 69.11% of the stock.
LPL Financial stock reiterated at outperform by Citizens on valuation
Citizens reiterated a Market Outperform rating and $500.00 price target on LPL Financial Holdings (NASDAQ:LPLA) stock, despite an 18% year-to-date decline attributed to softer net new assets, AI risk, and market pullback. The firm sees the current valuation as a compelling opportunity, with InvestingPro indicating the stock is undervalued and net income is expected to grow. Recent positive developments include an increase in advisory and brokerage assets, a new partnership with Simplicity Group, and upward revisions of price targets by Jefferies and Citizens following strong Q4 2025 results.
Capricorn Fund Managers Ltd Acquires Shares of 60,000 Evommune, Inc. $EVMN
Capricorn Fund Managers Ltd recently acquired 60,000 shares of Evommune, Inc. (NYSE:EVMN) in the fourth quarter, a stake valued at approximately $1.03 million. Evommune's stock performance shows a 52-week range of $13.89–$33.20 and a market capitalization of around $849.3 million, despite missing its recent quarterly EPS estimates. Analyst ratings for Evommune are predominantly "Buy," with a consensus price target of $47.17.
Franklin Income Focus ETF $INCM is Base Wealth Management LLC’s 6th Largest Position
Base Wealth Management LLC significantly increased its stake in the Franklin Income Focus ETF ($INCM) by 12.7% during the 4th quarter, making it their 6th largest holding. Other institutional investors like Raymond James Financial Inc. and Ameriprise Financial Inc. also raised their positions in the ETF. The article details the stock's performance and provides a profile of the Franklin Income Focus ETF, which aims to maximize income through a diversified portfolio of equities and debt securities.
Institutional Investors Increase Stakes in Devon Energy Amid Favorable Conditions
Institutional investors are increasing their holdings in Devon Energy (DVN) as crude oil prices exceed $100 per barrel and the company approaches its merger with Coterra Energy in Q2 2026. This strategic positioning aims to create a "Mega-Independent" producer with substantial free cash flow, bolstered by operational efficiencies and a strong capital return program for shareholders. Analysts at Raymond James have raised their price target due to anticipated strengthened free cash flow from elevated commodity prices.
Raymond James' AI-Proof Fortress: A Value Investor's Chance Amidst Market Downturn
Raymond James Financial Inc. experienced a significant stock drop due to investor fears about AI disrupting wealth management. However, the company is proactively integrating AI and maintaining strong financial performance, suggesting the market's reaction might be an overcorrection. For value investors, this presents a potential buying opportunity as the stock trades below its estimated intrinsic value, supported by robust fundamentals and a proactive approach to technological change.
Raymond James Financial (RJF) Valuation After Altruist AI Launch And Record Results
Raymond James Financial (RJF) shares experienced a 9% drop following competitor Altruist's launch of an AI-driven tax planning platform, despite RJF reporting record quarterly revenue and client assets. The stock is currently trading at $142.20, which is significantly undervalued compared to its fair value of $182.75, presenting a potential entry point for investors. The article emphasizes both the risks and rewards, encouraging investors to evaluate the underlying forecasts and potential market shifts.
BKU SEC Filings - Bankunited Inc 10-K, 10-Q, 8-K Forms
This page on Stock Titan provides comprehensive access to Bankunited (BKU) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K material event filings, and insider trading forms. It highlights how investors can use these documents to understand the company's financial condition, operations, and governance. The platform also offers AI-powered summaries to simplify complex regulatory information and ensures real-time updates of new filings.
Stratos Wealth Partners LTD. Raises Position in Pacer Global Cash Cows Dividend ETF $GCOW
Stratos Wealth Partners LTD. significantly increased its stake in the Pacer Global Cash Cows Dividend ETF (BATS:GCOW) by 964.3% during the fourth quarter, bringing its total ownership to 292,781 shares valued at $12,068,000. Other institutional investors like Bank of America Corp DE, Raymond James Financial Inc., and Jones Financial Companies Lllp also adjusted their positions in the ETF. The article also provides details on the ETF's price performance, market capitalization, and company profile.
SG Americas Securities LLC Trims Stake in Canadian Solar Inc. $CSIQ
SG Americas Securities LLC reduced its stake in Canadian Solar Inc. by 58.8% in Q4, selling 138,830 shares and retaining 97,459 shares valued at $2.32 million. Despite this, other institutional investors like Goldman Sachs Group Inc. and MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased their positions. Canadian Solar reported a quarterly loss of $1.66 EPS and has a market cap of $894.72 million, with analysts holding a consensus "Hold" rating and an average price target of $17.66.
Hennion & Walsh Asset Management Inc. Buys New Stake in Invesco Next Gen Connectivity ETF $KNCT
Hennion & Walsh Asset Management Inc. reported acquiring a new stake of 4,059 shares, valued at approximately $544,000, in the Invesco Next Gen Connectivity ETF (NYSEARCA:KNCT) during Q4. Other institutional investors like Raymond James Financial Inc., Advisory Services Network LLC, and Fulcrum Equity Management also increased their positions. The Invesco Next Gen Connectivity ETF focuses on companies deriving revenue from future connectivity technologies.
Innovator U.S. Equity Buffer ETF – June $BJUN Shares Sold by Brookstone Capital Management
Brookstone Capital Management significantly reduced its stake in the Innovator U.S. Equity Buffer ETF – June (BJUN) by 96.9% in the fourth quarter, selling 563,951 shares and retaining 18,045 shares valued at $843,000. Despite this, other institutional investors like JPMorgan Chase & Co., Raymond James Financial Inc., HighTower Advisors LLC, Envestnet Asset Management Inc., and Penserra Capital Management LLC increased their holdings in the ETF. The article also provides details on BJUN's price performance, market capitalization, and a brief profile of the ETF.
Allspring Global Investments Holdings LLC Buys 11,043 Shares of Raymond James Financial, Inc. $RJF
Allspring Global Investments Holdings LLC increased its stake in Raymond James Financial, Inc. (NYSE:RJF) by 13.1%, purchasing an additional 11,043 shares. The firm now holds 95,603 shares valued at approximately $15.64 million, with institutional investors owning 83.83% of the company. Despite an insider sale by Bella Loykhter Allaire, Raymond James beat EPS estimates for the quarter and analysts maintain an average "Hold" rating with a $183 price target.
Allspring Global Investments Holdings LLC Reduces Position in Ingram Micro Holding Corporation $INGM
Allspring Global Investments Holdings LLC reduced its stake in Ingram Micro Holding Corporation by 4.1% in the fourth quarter, selling 42,235 shares. Despite this reduction, Ingram Micro reported strong quarterly earnings, surpassing analyst estimates with $0.96 EPS and $14.88 billion in revenue. The company also announced a $100 million share buyback program and increased its quarterly dividend, signaling management confidence.
Polunin Capital Partners Ltd Makes New $5.17 Million Investment in Galiano Gold Inc. $GAU
Polunin Capital Partners Ltd has made a new investment of $5.17 million in Galiano Gold Inc. (NYSEAMERICAN:GAU), purchasing over 1.86 million shares, which represents about 0.72% of Galiano Gold and is Polunin's 16th largest holding. Analyst sentiment for Galiano Gold is cautiously positive, with a consensus "Moderate Buy" rating and an average price target of $4.25. Galiano Gold is a Canada-based gold exploration company focused on projects in Guyana, and its stock currently trades around $2.56 with a market capitalization of approximately $668 million.
Raymond James Financial Receives 'Hold' Rating from Analysts
Raymond James Financial (NYSE:RJF) has received an average 'Hold' rating from twelve research firms, with eight analysts recommending 'Hold' and four suggesting 'Buy'. The average 12-month price target is set at $183. Bank of America and UBS Group maintained 'Neutral' ratings, while Barclays initiated coverage with an 'Overweight' rating and Weiss Ratings upgraded the stock to 'Buy'.
JPMorgan Chase & Co. Purchases 93,927 Shares of Matrix Service Company $MTRX
JPMorgan Chase & Co. significantly increased its stake in Matrix Service Company (NASDAQ:MTRX) by 44.1% in the third quarter, acquiring 93,927 additional shares, bringing their total holdings to 306,848 shares valued at approximately $4.01 million. Other institutional investors also adjusted their positions in MTRX. The company recently reported a quarterly EPS of ($0.02), missing the consensus estimate, and analysts project a full-year EPS of ($0.26), yet maintain a "Moderate Buy" consensus rating with an average target price of $20.50.
Raymond James Financial, Inc. (NYSE:RJF) Receives Consensus Rating of "Hold" from Analysts
Raymond James Financial (NYSE:RJF) has received a consensus "Hold" rating from twelve research firms, with an average one-year price target of $183.00. While some analysts maintained "hold" or "neutral" ratings, Barclays initiated coverage with an "overweight" rating and Weiss upgraded the stock to a "buy." The company recently reported quarterly earnings, beating EPS estimates but missing revenue expectations, and declared a quarterly dividend of $0.54.
UnitedHealth Group Upgraded to Outperform by Raymond James
Raymond James Financial has upgraded UnitedHealth Group (NYSE: UNH) from a 'market perform' to an 'outperform' rating, setting a price target of $330. This upgrade, despite recent headwinds in the healthcare industry, is based on UnitedHealth Group's diversified business model and strong market position through its UnitedHealthcare and Optum divisions. Investors will be monitoring the company's ability to reach this new price target.
Raymond James Financial stock: Steady performer with 9% upside potential?
Raymond James Financial is presented as a stable investment opportunity in the wealth management sector, particularly for North American investors. The article highlights its diversified business model, client-focused services, and strong financial health as key strengths. Analysts foresee a 9% upside potential from current levels, recommending it for buy-and-hold investors despite some market risks.
Raymond James Financial stock: Steady performer with 9% upside potential?
This article analyzes Raymond James Financial (RJF), highlighting its resilient business model as a diversified financial services firm focusing on wealth management, capital markets, and asset management. It discusses RJF's competitive edge through its independent, advisor-centric approach and solid financial health, including consistent revenue growth and dividend payouts. Analyst perspectives suggest a stable "hold" rating with a potential 9% upside, making RJF a suitable long-term investment for North American investors seeking stability and growth in the wealth management sector.
State Street Corporation (STT) stock price, news, quote and history
This page provides comprehensive financial information for State Street Corporation (STT), including its current stock price, dividend details, historical performance, and key financial metrics. It also features recent news articles related to State Street, showcasing its role in asset management and financial services, and includes analyst ratings and comparisons with similar companies.
RadNet at Raymond James Conference: Embracing AI for Growth
RadNet Inc. (NASDAQ:RDNT) presented its strategic vision at the 47th Annual Raymond James Institutional Investor Conference, emphasizing its expansion in digital health and AI. The company projects significant revenue growth for 2026, with imaging centers expected to grow by 16-18% and digital health by 50%. CFO Mark Stolper outlined plans for AI integration and new center openings to drive future growth, while also acknowledging challenges like rising labor costs and weather impacts.
Pacific Sage Partners LLC Sells 30,922 Shares of Sprott Physical Gold and Silver Trust $CEF
Pacific Sage Partners LLC reduced its stake in Sprott Physical Gold and Silver Trust (CEF) by 11.4% in the fourth quarter, selling 30,922 shares and ending with 239,587 shares valued at $10.97 million. The trust represents 1.7% of Pacific Sage Partners' portfolio, making it its 16th largest holding. Conversely, several other institutional investors, including Jupiter Asset Management, Bleakley Financial, Raymond James, Ameriprise, and Bank of America Corp DE, increased their positions in CEF during recent quarters.
The Walt Disney Company $DIS Shares Purchased by HF Advisory Group LLC
HF Advisory Group LLC significantly increased its stake in The Walt Disney Company (NYSE:DIS) by 746.2% in the fourth quarter, now owning 99,159 shares valued at $11.28 million. Wall Street analysts maintain a "Moderate Buy" rating with a consensus price target of $132.81, supported by recent earnings beats and a 72% rise in streaming operating income. Despite positive sentiment and strong Q1 results, some analysts caution about operational headwinds, weak near-term cash flow, and potential setbacks in AI partnership talks.
UnitedHealth Group Shares Rise After Analyst Upgrade
UnitedHealth Group's shares rose 1.2% after Raymond James Financial upgraded the stock from 'market perform' to 'outperform' with a $330 price target. This upgrade reflects the company's strong market position and growth potential, despite recent headwinds. Investors are now keenly awaiting the company's upcoming earnings report.
